Risk of cancer in patients with psoriasis on biological therapies: a systematic review. [electronic resource]
Producer: 20190409Description: 103-113 p. digitalISSN:- 1365-2133
- Adalimumab -- adverse effects
- Adult
- Biological Products -- adverse effects
- Dermatologic Agents -- adverse effects
- Epidemiologic Methods
- Etanercept -- adverse effects
- Female
- Humans
- Infliximab -- adverse effects
- Male
- Middle Aged
- Neoplasms -- chemically induced
- Psoriasis -- drug therapy
- Risk Factors
- Ustekinumab -- adverse effects
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.